US stock screener
Every US-listed company we cover. Most columns are company-reported figures from each company’s own SEC filings; P/E, market cap and dividend yield are market-derived, combining SEC share counts and TTM results with a stored price, last retrieved on a rolling basis and typically within the past week. Click a column to sort, or open a company for its full statements with per-figure provenance.
| Company | Sector | Market cap | Revenue (FY) | Rev growth | Net margin | ROE | P/E (TTM) | Div yield |
|---|---|---|---|---|---|---|---|---|
| Organogenesis Holdings Inc. (ORGO) | Healthcare | $131.2Mpit | $564.2M | 17.0% | 6.6% | — | — | — |
| HUTCHMED (China) Ltd (HCM) | Healthcare | $2.44Bvendor | $548.5M | -13.0% | 83.3% | 36.5% | — | — |
| AtriCure, Inc. (ATRC) | Healthcare | $3.00Bpit | $534.5M | 14.9% | -2.1% | -2.3% | — | — |
| Mirum Pharmaceuticals, Inc. (MIRM) | Healthcare | $5.34Bpit | $521.3M | 54.7% | -4.5% | -7.4% | — | — |
| Veracyte, Inc. (VCYT) | Healthcare | $3.52Bpit | $517.1M | 16.0% | 12.8% | 5.1% | 31.3 | — |
| Inotiv, Inc. (NOTVQ) | Healthcare | $390,419vendor | $513.0M | 4.5% | -13.4% | -50.4% | — | — |
| Adma Biologics, Inc. (ADMA) | Healthcare | $2.47Bpit | $510.2M | 19.6% | 28.8% | 30.8% | 15.7 | — |
| GLAUKOS Corp (GKOS) | Healthcare | $9.85Bpit | $507.4M | 32.3% | -37.0% | -28.6% | — | — |
| Starling Oncology, Inc. (STLN) | Healthcare | $658.4Mpit | $502.7M | 27.8% | -12.1% | — | — | — |
| BridgeBio Pharma, Inc. (BBIO) | Healthcare | $13.40Bpit | $502.1M | 126.3% | — | — | — | — |
| Ascend Wellness Holdings, Inc. (AAWH) | Healthcare | $85.8Mpit | $500.6M | -10.9% | -23.6% | — | — | — |
| Travere Therapeutics, Inc. (TVTX) | Healthcare | $4.76Bpit | $490.7M | 110.5% | -5.2% | -22.2% | — | — |
| Natures Sunshine Products Inc. (NATR) | Healthcare | $220.8Mpit | $480.1M | 5.7% | 4.1% | 12.1% | 12.5 | — |
| Ayr Wellness Inc. (AYRWF) | Healthcare | $432,062vendor | $463.6M | 0.0% | -77.5% | -98.5% | — | — |
| Zai Lab Ltd (ZLAB) | Healthcare | $2.82Bvendor | $457.2M | 15.0% | -38.4% | -24.5% | — | — |
| Tarsus Pharmaceuticals, Inc. (TARS) | Healthcare | $3.05Bpit | $451.4M | 146.7% | -14.7% | -19.3% | — | — |
| Artivion, Inc. (AORT) | Healthcare | $1.12Bpit | $441.3M | 13.6% | 2.2% | 2.2% | — | — |
| GeneDx Holdings Corp. (WGS) | Healthcare | $1.98Bpit | $427.5M | 40.0% | -4.9% | -6.8% | — | — |
| Mimedx Group, Inc. (MDXG) | Healthcare | $638.4Mpit | $418.6M | 20.0% | 11.6% | 18.9% | 106 | — |
| Innoviva, Inc. (INVA) | Healthcare | $1.52Bpit | $411.3M | 14.7% | 65.9% | 23.1% | 5.2 | — |
| Ardelyx, Inc. (ARDX) | Healthcare | $770.0Mpit | $407.3M | 22.1% | -15.1% | -36.9% | — | — |
| Esperion Therapeutics, Inc. (ESPR) | Healthcare | $819.5Mvendor | $403.1M | 21.3% | -5.6% | — | — | — |
| Accuray Inc. (ARAY) | Healthcare | $17.1Mpit | $401.9M | -12.3% | -12.2% | -118.0% | — | — |
| Immunocore Holdings plc (IMCR) | Healthcare | $1.54Bpit | $400.0M | 29.0% | -8.9% | -9.3% | — | — |
| Krystal Biotech, Inc. (KRYS) | Healthcare | $9.48Bpit | $389.1M | 33.9% | 52.6% | 16.8% | 40.2 | — |
| Sinovac Biotech Ltd. (SVA) | Healthcare | — | $386.0M | 6.8% | -51.5% | -3.1% | — | — |
| Sonida Senior Living, Inc. (SNDA) | Healthcare | $1.64Bpit | $381.1M | 25.2% | -18.6% | — | — | — |
| CareDx, Inc. (CDNA) | Healthcare | $3.31Bpit | $379.8M | 13.8% | -5.6% | -7.0% | — | — |
| Twist Bioscience Corp (TWST) | Healthcare | $8.76Bpit | $376.6M | 20.3% | -20.6% | -16.4% | — | — |
| Arcutis Biotherapeutics, Inc. (ARQT) | Healthcare | $4.01Bpit | $372.1M | 123.4% | -4.3% | -8.5% | — | — |
| InMode Ltd. (INMD) | Healthcare | $809.6Mvendor | $370.5M | -6.2% | 25.3% | 13.7% | — | — |
| Mannkind Corp. (MNKD) | Healthcare | $993.6Mpit | $349.0M | 22.2% | 1.7% | — | — | — |
| Castle Biosciences Inc. (CSTL) | Healthcare | $982.6Mpit | $344.2M | 3.7% | -7.0% | -5.1% | — | — |
| Tactile Systems Technology Inc. (TCMD) | Healthcare | $514.9Mpit | $329.5M | 12.5% | 5.8% | 8.7% | 21.1 | — |
| Fulgent Genetics, Inc. (FLGT) | Healthcare | $553.1Mpit | $322.7M | 13.8% | -18.8% | -5.5% | — | — |
| DocGo Inc. (DCGO) | Healthcare | $26.9Mpit | $322.2M | -47.7% | -56.6% | -144.9% | — | — |
| Angiodynamics Inc. (ANGO) | Healthcare | $500.0Mpit | $320.2M | 9.5% | -11.5% | -21.5% | — | — |
| CorMedix Inc. (CRMD) | Healthcare | $575.2Mpit | $311.7M | 617.0% | 52.3% | 40.2% | — | — |
| PROCEPT BioRobotics Corp (PRCT) | Healthcare | $1.05Bpit | $308.1M | 37.2% | -31.0% | -26.1% | — | — |
| BillionToOne, Inc. (BLLN) | Healthcare | $4.88Bpit | $305.1M | 100.0% | 2.4% | 1.6% | 139 | — |
| SkinHealth Systems Inc. (SKIN) | Healthcare | $68.6Mvendor | $300.8M | -10.0% | -3.2% | -15.6% | — | — |
| Evolus, Inc. (EOLS) | Healthcare | $486.1Mpit | $297.2M | 11.6% | -17.4% | — | — | — |
| Ironwood Pharmaceuticals Inc. (IRWD) | Healthcare | $588.3Mpit | $296.2M | -15.7% | 8.1% | — | 4.7 | — |
| Inogen Inc (INGN) | Healthcare | $173.8Mpit | $295.3M | 5.9% | -7.7% | -11.8% | — | — |
| Rigel Pharmaceuticals Inc. (RIGL) | Healthcare | $872.7Mpit | $294.3M | 64.1% | — | 93.8% | 2.9 | — |
| Xeris Biopharma Holdings, Inc. (XERS) | Healthcare | $2.00Bpit | $291.8M | 43.7% | 0.2% | 4.0% | — | — |
| Aurinia Pharmaceuticals Inc. (AUPH) | Healthcare | $2.24Bpit | $283.1M | 20.4% | — | 49.4% | 7.4 | — |
| Adaptive Biotechnologies Corp (ADPT) | Healthcare | $3.90Bpit | $277.0M | 54.8% | -21.5% | -26.4% | — | — |
| Vericel Corp (VCEL) | Healthcare | $2.10Bpit | $276.3M | 16.5% | 6.0% | 4.7% | 96.9 | — |
| Harrow, Inc. (HROW) | Healthcare | $1.04Bpit | $272.3M | 36.4% | -1.9% | -9.9% | — | — |
| Viemed Healthcare, Inc. (VMD) | Healthcare | $371.4Mpit | $270.3M | 20.5% | 5.5% | 10.4% | 27.0 | — |
| Vireo Growth Inc. (VREOF) | Healthcare | $466.7Mvendor | $268.8M | 170.4% | -25.3% | -22.2% | — | — |
| Ligand Pharmaceuticals Inc. (LGND) | Healthcare | $6.28Bpit | $268.1M | 60.4% | 46.4% | 12.2% | 33.5 | — |
| Iovance Biotherapeutics, Inc. (IOVA) | Healthcare | $6.44Bpit | $263.5M | 60.6% | — | -56.0% | — | — |
| Jushi Holdings Inc. (JUSH) | Healthcare | $109.4Mpit | $262.9M | 2.1% | -26.1% | — | — | — |
| Arvinas, Inc. (ARVN) | Healthcare | $477.3Mpit | $262.6M | -0.3% | -30.8% | -18.6% | — | — |
| Omada Health, Inc. (OMDA) | Healthcare | $1.20Bpit | $260.2M | 53.2% | -4.9% | -5.6% | — | — |
| Schrodinger, Inc. (SDGR) | Healthcare | $1.75Bpit | $255.9M | 23.3% | -40.4% | -28.4% | — | — |
| Lemaitre Vascular Inc. (LMAT) | Healthcare | $1.91Bpit | $249.6M | 13.5% | 23.1% | 14.7% | 29.4 | 1.1% |
| Arcus Biosciences, Inc. (RCUS) | Healthcare | $2.43Bpit | $247.0M | -4.3% | — | -55.9% | — | — |
| Keros Therapeutics, Inc. (KROS) | Healthcare | $221.7Mpit | $243.9M | 6769.4% | 35.7% | 28.7% | — | — |
| Staar Surgical Co. (STAA) | Healthcare | $1.10Bpit | $239.4M | -23.7% | -33.6% | -23.4% | — | — |
| Vaxart, Inc. (VXRT) | Healthcare | $116.6Mpit | $237.3M | 726.7% | 6.9% | 18.6% | — | — |
| Orthopediatrics Corp. (KIDS) | Healthcare | $622.5Mpit | $236.3M | 15.4% | -16.8% | -11.4% | — | — |
| Akebia Therapeutics, Inc. (AKBA) | Healthcare | $155.8Mpit | $236.2M | 47.5% | -2.3% | -16.4% | — | — |
| Anaptysbio, Inc. (ANAB) | Healthcare | $1.44Bpit | $234.6M | 157.0% | -5.6% | -35.6% | — | — |
| Cerus Corp. (CERS) | Healthcare | $439.3Mpit | $233.8M | 16.1% | -6.7% | -24.1% | — | — |
| Talkspace, Inc. (TALK) | Healthcare | $870.6Mvendor | $228.9M | 22.0% | 3.4% | 6.7% | — | — |
| Puma Biotechnology, Inc. (PBYI) | Healthcare | $562.7Mpit | $228.4M | -0.9% | 13.6% | 23.9% | 20.9 | — |
| Axogen, Inc. (AXGN) | Healthcare | $1.96Bpit | $225.2M | 20.2% | -7.0% | -12.2% | — | — |
| IDEAYA Biosciences, Inc. (IDYA) | Healthcare | $3.49Bpit | $218.7M | 3024.4% | -52.0% | -11.1% | — | — |
| Vanda Pharmaceuticals Inc. (VNDA) | Healthcare | $242.5Mpit | $216.1M | 8.7% | — | -67.4% | — | — |
| Amarin Corp. Plc\uk (AMRN) | Healthcare | $243.1Mvendor | $213.6M | -6.5% | -18.2% | -8.4% | — | — |
| Treace Medical Concepts, Inc. (TMCI) | Healthcare | $277.7Mpit | $212.7M | 1.6% | -27.7% | -67.6% | — | — |
| Establishment Labs Holdings Inc. (ESTA) | Healthcare | $1.89Bpit | $211.1M | 27.1% | -24.2% | -216.9% | — | — |
| Cytek Biosciences, Inc. (CTKB) | Healthcare | $714.9Mpit | $201.5M | 0.5% | -33.0% | -19.5% | — | — |
| SI-BONE, Inc. (SIBN) | Healthcare | $962.7Mpit | $200.9M | 20.2% | -9.4% | -10.6% | — | — |
| Strata Critical Medical, Inc. (SRTA) | Healthcare | $412.3Mpit | $197.1M | 34.3% | 21.0% | 14.8% | 9.2 | — |
| LifeMD, Inc. (LFMD) | Healthcare | $104.6Mpit | $194.1M | 25.3% | 7.4% | 62.0% | — | — |
| Lakeland Industries Inc. (LAKE) | Healthcare | $91.7Mpit | $192.6M | 15.2% | -13.1% | -19.6% | — | — |
| biote Corp. (BTMD) | Healthcare | $36.3Mvendor | $192.2M | -2.5% | 14.1% | — | — | — |
| Rhythm Pharmaceuticals, Inc. (RYTM) | Healthcare | $6.15Bpit | $189.8M | 45.8% | — | — | — | — |
| Maravai Lifesciences Holdings, Inc. (MRVI) | Healthcare | $2.67Bvendor | $185.7M | -28.3% | -70.4% | -35.1% | — | — |
| Stoke Therapeutics, Inc. (STOK) | Healthcare | $1.62Bpit | $184.4M | 404.5% | -3.7% | -2.0% | — | — |
| Lifevantage Corp (LFVN) | Healthcare | $74.9Mpit | $182.6M | -20.1% | 2.8% | 15.1% | 14.9 | 3.1% |
| Glass House Brands Inc. (GLAS) | Healthcare | $214.9Mvendor | $182.0M | -9.4% | -16.3% | — | — | — |
| Adaptimmune Therapeutics PLC (ADAPY) | Healthcare | $8.0Mvendor | $178.0M | 195.3% | -39.8% | -597.6% | — | — |
| Cryoport, Inc. (CYRX) | Healthcare | $938.5Mpit | $176.2M | 12.4% | 44.4% | 15.6% | — | — |
| Heartflow, Inc. (HTFL) | Healthcare | $4.82Bpit | $176.0M | 39.9% | -66.3% | -38.8% | — | — |
| Phathom Pharmaceuticals, Inc. (PHAT) | Healthcare | $567.1Mpit | $175.1M | 216.9% | — | — | — | — |
| SBC Medical Group Holdings Inc (SBC) | Healthcare | $543.0Mpit | $173.6M | -15.5% | 29.4% | 19.4% | 11.3 | — |
| Syndax Pharmaceuticals Inc (SNDX) | Healthcare | $1.20Bpit | $172.4M | 627.8% | — | -441.6% | — | — |
| REGENXBIO Inc. (RGNX) | Healthcare | $441.0Mpit | $170.4M | 104.5% | — | -188.7% | — | — |
| Ginkgo Bioworks Holdings, Inc. (DNA) | Healthcare | $664.0Mpit | $170.2M | -25.1% | — | -61.5% | — | — |
| Pacific Biosciences of California, Inc. (PACB) | Healthcare | $640.3Mpit | $160.0M | 3.9% | — | -10214.5% | — | — |
| Marimed Inc. (MRMD) | Healthcare | $22.2Mpit | $159.8M | 1.3% | -9.1% | — | — | — |
| Liquidia Corp (LQDA) | Healthcare | $3.55Bpit | $158.3M | 1031.2% | -43.5% | -154.0% | — | — |
| Heron Therapeutics, Inc. (HRTX) | Healthcare | $56.2Mpit | $154.9M | 7.4% | -13.0% | -140.9% | — | — |
| Airsculpt Technologies, Inc. (AIRS) | Healthcare | $86.5Mpit | $151.8M | -15.8% | -7.7% | -13.3% | — | — |
| Macrogenics Inc. (MGNX) | Healthcare | $231.2Mpit | $149.5M | -0.3% | -49.9% | -134.2% | — | — |
Want more than a table?
Sign in to screen with custom filters (growth, ROIC, insider buying, short interest and 30+ more metrics), compare peers side by side, and get filing-grounded answers with citations. Free to start.
Start freeFundamentals from SEC EDGAR, as reported; valuation columns combine SEC filings with market data and are blanked where the two sources disagree. Informational only. Not investment advice.